These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2954733)

  • 1. A morphometric reevaluation of Huntington's chorea with special reference to the large neurons in the neostriatum.
    Oyanagi K; Ikuta F
    Clin Neuropathol; 1987; 6(2):71-9. PubMed ID: 2954733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntington's disease: survival of large striatal neurons in the rigid variant.
    Bugiani O; Tabaton M; Cammarata S
    Ann Neurol; 1984 Feb; 15(2):154-6. PubMed ID: 6230987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons.
    Cicchetti F; Parent A
    Mov Disord; 1996 Nov; 11(6):619-26. PubMed ID: 8914086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical investigation of the human neostriatum in Huntington's disease.
    Goto S; Hirano A; Rojas-Corona RR
    Ann Neurol; 1989 Mar; 25(3):298-304. PubMed ID: 2543263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
    Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Huntington disease: 7 cases with relatively preserved neostriatal islets].
    Vonsattel JP; Myers RH; Bird ED; Ge P; Richardson EP
    Rev Neurol (Paris); 1992; 148(2):107-16. PubMed ID: 1534925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology of acute cell loss in Huntington's chorea brain.
    Averback P
    J Pathol; 1980 Sep; 132(1):55-61. PubMed ID: 6448921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropathological features of neuroacanthocytosis.
    Rinne JO; Daniel SE; Scaravilli F; Pires M; Harding AE; Marsden CD
    Mov Disord; 1994 May; 9(3):297-304. PubMed ID: 8041370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.
    Richfield EK; Herkenham M
    Ann Neurol; 1994 Oct; 36(4):577-84. PubMed ID: 7944290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An autopsy case of chorea-acanthocytosis. Special reference to the histopathological and biochemical findings of basal ganglia].
    Sato Y; Ohnishi A; Tateishi J; Onizuka Y; Ishimoto S; Iwashita H; Kuroiwa Y; Kanazawa I
    No To Shinkei; 1984 Feb; 36(2):105-11. PubMed ID: 6203544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients.
    Richfield EK; Maguire-Zeiss KA; Vonkeman HE; Voorn P
    Ann Neurol; 1995 Dec; 38(6):852-61. PubMed ID: 8526457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients.
    Richfield EK; Maguire-Zeiss KA; Cox C; Gilmore J; Voorn P
    Ann Neurol; 1995 Mar; 37(3):335-43. PubMed ID: 7695232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative investigation of the substantia nigra in Huntington's disease.
    Oyanagi K; Takeda S; Takahashi H; Ohama E; Ikuta F
    Ann Neurol; 1989 Jul; 26(1):13-9. PubMed ID: 2528318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.
    Augood SJ; Faull RL; Emson PC
    Ann Neurol; 1997 Aug; 42(2):215-21. PubMed ID: 9266732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.
    Capetian P; Knoth R; Maciaczyk J; Pantazis G; Ditter M; Bokla L; Landwehrmeyer GB; Volk B; Nikkhah G
    Neuroscience; 2009 May; 160(3):661-75. PubMed ID: 19254752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic conference. Huntington's chorea.
    Dis Nerv Syst; 1972 Sep; 33(9):626-31. PubMed ID: 4265280
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.